Selected fused pyrrolocarbazoles
AssigneeCephalon, Inc.
InventorsDiane Gingrich, Robert Hudkins
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to selected fused pyrrolocarbazoles, including pharmaceutical compositions thereof and methods of treating diseases therewith. The present invention is also directed to intermediates and processes for making these fused pyrrolocarbazoles.
Claims16
A method for treating prostate disorders which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of Formula I:
- wherein:
- R3 is alkyl of 1-8 carbons substituted with —OH or —SR5;
- R5 is alkyl of 1-4 carbons.
A method for treating angiogenic disorders which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of Formula I:
- wherein:
- R3 is alkyl of 1-8 carbons substituted with —OH or —SR5;
- R5 is alkyl of 1-4 carbons.
A method for treating pathological disorders which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of Formula I:
- wherein:
- R3is alkyl of 1-8 carbons substituted with —OH or —SR5;
- R5 is alkyl of 1-4 carbons.
A method for treating neurodegenerative diseases and disorders, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia, epilepsy, multiple sclerosis, peripheral neuropathy, chemotherapy induced peripheral neuropathy, AID related peripheral neuropathy or injuries of the brain or spinal chord which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of Formula I:
- wherein:
- R3 is alkyl of 1-8 carbons substituted with —OH or —SR5;
- R5 is alkyl of 1-4 carbons.
A method for treating multiple myeloma and leukemias which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of Formula I:
- wherein:
- R3 is alkyl of 1-8 carbons substituted with —OH or —SR5;
- R5 is alkyl of 1-4 carbons.
A method for treating angiogenic disorders which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of Formula I:
- wherein R1 and R3 are selected in accordance with the following table:
- Cmpd
- R1
- R3
- 37
- CH2CH2CH2OCOCF3
- CH2SCH2CH2CH3
- 39
- CH2CH2CH2OH
- CH2S(2-pyrimidyl)
A method for treating pathological disorders which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of Formula I:
- wherein R1 and R3 are selected in accordance with the following table:
- Cmpd
- R1
- R3
- 37
- CH2CH2CH2OCOCF3
- CH2SCH2CH2CH3
- 39
- CH2CH2CH2OH
- CH2S(2-pyrimidyl)
A method for treating neurodegenerative diseases and disorders, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia, epilepsy, multiple sclerosis, peripheral neuropathy, chemotherapy induced peripheral neuropathy, AID related peripheral neuropathy or injuries of the brain or spinal chord which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of Formula I:
- wherein R1 and R3 are selected in accordance with the following table:
- Cmpd
- R1
- R3
- 37
- CH2CH2CH2OCOCF3
- CH2SCH2CH2CH3
- 39
- CH2CH2CH2OH
- CH2S(2-pyrimidyl)
A method for treating multiple myeloma and leukemias which comprise administering to a host in need of such treatment or prevention a therapeutically effective amount of a compound of Formula I:
- wherein R1 and R3 are selected in accordance with the following table:
- Cmpd
- R1
- R3
- 37
- CH2CH2CH2OCOCF3
- CH2SCH2CH2CH3
- 39
- CH2CH2CH2OH
- CH2S(2-pyrimidyl)
Dependencies are inferred from the claim text.